The Future of Brain Health
Founded in 2024 by neurologist and health-system executive Dr. Rany Aburashed, Neurogen Biomarking was built on a clear promise: deliver expert, premium brain-health care that is accessible to everyone, and treat every family like our own. Headquartered in Chicago, with leadership and operations across the United States, the company serves three primary markets: U.S. healthcare systems, employer health networks, and proactive consumers. Neurogen's mission is to democratize early detection and management of brain health so that patients and families are no longer failed by late diagnoses. The company's early traction reflects real demand, a waitlist exceeding 1,000 individuals before formal launch, and a beta cohort of more than 500 participants reporting 98% satisfaction.